Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma (Q80332885)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 September 2006
edit
Language Label Description Also known as
English
Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma
scientific article published on 22 September 2006

    Statements

    Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit